Evidence map›Paper›PMID 37650531›Full record

ReviewJournal of clinical laboratory analysis2023

Prediction of tsunami of resistance to some antibiotics is not far-fetched which used during COVID-19 pandemic.

Mandana Hosseini, Mohammed Ahmed Hamad, Golazin Mohseni, Shakiba Salamy, Shabnam Dehghan Tarzjani, Majid Taati Moghadam

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical laboratory analysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Mandana HosseiniDepartment of Microbiology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Mohammed Ahmed HamadStudent Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Golazin MohseniDepartment of Microbiology, Tonekabon Branch, Azad University, Tonekabon, Iran.
Shakiba SalamyDepartment of Microbiology, Faculty of Pharmacy, Islamic Azad University, Tehran, Iran.
Shabnam Dehghan TarzjaniDepartment of Cellular and Molecular Biology, Tehran Center Branch, Islamic Azad University, Tehran, Iran.
Majid Taati MoghadamDepartment of Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0003-1557-3648
Islamic Azad University, Tehran · IRGuilan University of Medical Sciences · IRIslamic Azad University North Tehran Branch · IRIslamic Azad University Tonekabon · IRKermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most tragic events in recent history was the COVID-19 outbreak, which has caused thousands of deaths. A variety of drugs were prescribed to improve the condition of patients, including antiparasitic, antiviral, antibiotics, and anti-inflammatory medicines. It must be understood, however, that COVID-19 is like a tip of an iceberg on the ocean, and the consequences of overuse of antibiotics are like the body of a mountain under water whose greatness has not yet been determined for humanity, and additional study is needed to understand them. History of the war between microbes and antimicrobial agents has shown that microbes are intelligent organisms that win over antimicrobial agents over time through many acquired or inherent mechanisms. The key terms containing "COVID-19," "Severe acute respiratory syndrome coronavirus-2," "SARS-CoV2," "Antibiotic Resistance," "Coronavirus," "Pandemic," "Antibiotics," and "Antimicrobial Resistance" were used for searching in PubMed, Scopus, and Google Scholar databases. The COVID-19 pandemic has resulted in an increased prescription of antibiotics. Infections caused by secondary or co-bacterial infections or beneficial bacteria in the body can be increased as a result of this amount of antibiotic prescription and exposure to antibiotics. Antibiotic resistance will likely pose a major problem in the future, especially for last resort antibiotics. In order to address the antibiotic resistance crisis, it is imperative that researchers, farmers, veterinarians, physicians, public and policymakers, pharmacists, other health and environmental professionals, and others collaborate during and beyond this pandemic.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialCOVID-19HumansPandemicsSARS-CoV-2Anti-Bacterial Agentsantibioticsantimicrobial resistanceCOVID-19pandemicvaccines

Identifiers

PMID37650531
PMCPMC10561589
OpenAlexW4386305180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.